Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
出版年份 2021 全文链接
标题
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
作者
关键词
Protein kinase inhibitors, Molecular hybridization, Multiple target therapy, Anticancer
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 225, Issue -, Pages 113768
出版商
Elsevier BV
发表日期
2021-08-14
DOI
10.1016/j.ejmech.2021.113768
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protein kinase inhibitor-based cancer therapies: Considering the potential of nitric oxide (NO) to improve cancer treatment
- (2020) Silvia Ghione et al. BIOCHEMICAL PHARMACOLOGY
- Enhanced antitumor potential induced by chloroacetate-loaded benzophenones acting as fused tubulin-pyruvate dehydrogenase kinase 1 (PDHK1) ligands
- (2020) Alina Ghinet et al. BIOORGANIC CHEMISTRY
- Discovery of novel cyclin-dependent kinase (CDK) and histone deacetylase (HDAC) dual inhibitors with potent in vitro and in vivo anticancer activity
- (2020) Chunhui Cheng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226
- (2020) Heba F. Ashour et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dual-target kinase drug design: Current strategies and future directions in cancer therapy
- (2020) Dejuan Sun et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Current and future role of fedratinib in the treatment of myelofibrosis
- (2020) Monica Ragheb et al. Future Oncology
- Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors
- (2020) Ning-Yu Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel HSP90-PI3K Dual Inhibitor Suppresses Melanoma Cell Proliferation by Interfering with HSP90-EGFR Interaction and Downstream Signaling Pathways
- (2020) Qian Zhao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer
- (2020) Celia Pinto-Díez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors
- (2020) Ashish Thakur et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 Inhibitors
- (2020) Regina Martínez et al. MOLECULES
- Synthesis and Biological Evaluation of 2-Substituted Benzyl-/Phenylethylamino-4-amino-5-aroylthiazoles as Apoptosis-Inducing Anticancer Agents
- (2020) Paola Oliva et al. MOLECULES
- New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation
- (2020) Eman T. Warda et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthetic approaches, anticancer potential, HSP90 inhibition, multitarget evaluation, molecular modeling and apoptosis mechanistic study of thioquinazolinone skeleton: Promising antibreast cancer agent
- (2020) Hamed W. El-Shafey et al. BIOORGANIC CHEMISTRY
- Design, synthesis and evaluation of 2,4‐diaminoquinazoline derivatives as potential tubulin polymerization inhibitors
- (2020) Francisco Hernández-Luis et al. ChemMedChem
- Design, synthesis and biological evaluation of novel histone deacetylase1/2 (HDAC1/2) and cyclin-dependent Kinase2 (CDK2) dual inhibitors against malignant cancer
- (2020) Fan Yun et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An evaluation of Ibrutinib for the treatment of Waldenstrom macroglobulinaemia
- (2020) Kenneth J. C. Lim et al. EXPERT OPINION ON PHARMACOTHERAPY
- The off-label uses profile of tofacitinib in systemic rheumatic diseases
- (2020) Zichu Zhao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Design and Synthesis of a Trifunctional Molecular System “Programmed” to Block Epidermal Growth Factor Receptor Tyrosine Kinase, Induce High Levels of DNA Damage, and Inhibit the DNA Repair Enzyme (Poly(ADP-ribose) Polymerase) in Prostate Cancer Cells
- (2020) Julie Schmitt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design and Evaluation of 6-(Pyrimidin-2-ylamino)-3,4-dihydroquinoxalin-2(1H)-ones as Polypharmacological Inhibitors of BET and Kinases
- (2020) Kaikai Lv et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biological Evaluation of Shishijimicin A-Type Linker-Drugs and Antibody–Drug Conjugates
- (2020) K. C. Nicolaou et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation
- (2020) Adel A. Marzouk et al. BIOORGANIC CHEMISTRY
- LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumors
- (2020) Bo Zhong et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Design, Synthesis and Bioactivity Evaluation of 4,6-Disubstituted Pyrido[3,2-d]pyrimidine Derivatives as Mnk and HDAC Inhibitors
- (2020) Kun Xing et al. MOLECULES
- Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma Growth
- (2020) Ling Zeng et al. Frontiers in Genetics
- Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors
- (2020) Yuhong Dong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors
- (2019) Romeo Romagnoli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
- (2019) Kinsie E Arnst et al. MEDICINAL RESEARCH REVIEWS
- Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies
- (2019) Xuewu Liang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity
- (2019) Ellen Watts et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer
- (2019) Canan Kasikara et al. CANCER RESEARCH
- Design, synthesis, and docking study of new quinoline derivatives as antitumor agents
- (2019) Eman E. Nasr et al. ARCHIV DER PHARMAZIE
- Antibody-drug conjugates of 7-ethyl-10-hydroxycamptothecin: Sacituzumab govitecan and labetuzumab govitecan
- (2019) Wenjuan Dong et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- S-nitrosothiols and H2S donors: Potential chemo-therapeutic agents in cancer
- (2019) Adriana Karla Cardoso Amorim Reis et al. Redox Biology
- Towards anticancer fluoroquinolones: A review article
- (2019) Mohamed A. A. Abdel‐Aal et al. ARCHIV DER PHARMAZIE
- Discovery of novel 9H-purin derivatives as dual inhibitors of HDAC1 and CDK2
- (2019) Yu Yu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
- (2019) Viktoriya Ivasiv et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Alpelisib: First Global Approval
- (2019) Anthony Markham DRUGS
- A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade
- (2019) Xiaoxia Liang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors
- (2019) Hang Dong et al. MOLECULES
- FGF19–FGFR4 Signaling in Hepatocellular Carcinoma
- (2019) Aroosha Raja et al. Cells
- Design, Synthesis and Biological Evaluation of Novel Benzoylimidazole Derivatives as Raf and Histone Deacetylases Dual Inhibitors
- (2019) Xin Chen et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents
- (2019) Mohamed Hisham et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors
- (2019) Gavin W. Collie et al. ACS Medicinal Chemistry Letters
- Protein targeting chimeric molecules specific for dual bromodomain 4 (BRD4) and Polo-like kinase 1 (PLK1) proteins in acute myeloid leukemia cells
- (2019) Xupeng Mu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Introducing of acyclonucleoside analogues tethered 1,2,4-triazole as anticancer agents with dual epidermal growth factor receptor kinase and microtubule inhibitors
- (2019) Mohamed Reda Aouad et al. BIOORGANIC CHEMISTRY
- Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets
- (2019) Žiga Skok et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of an Oleanolic Acid/Hederagenin–Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer
- (2019) Zhong Chen et al. JOURNAL OF NATURAL PRODUCTS
- Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A
- (2019) Sana Waheed et al. MOLECULES
- Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR
- (2019) Wen-Xue Sun et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of Novel Dual Poly(ADP-ribose)polymerase and Phosphoinositide 3-Kinase Inhibitors as a Promising Strategy for Cancer Therapy
- (2019) Junwei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic
- (2018) John L. Wallace et al. ANTIOXIDANTS & REDOX SIGNALING
- Design, synthesis and evaluate of novel dual FGFR1 and HDAC inhibitors bearing an indazole scaffold
- (2018) Jian Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design and synthesis of triple inhibitors of janus kinase (JAK), histone deacetylase (HDAC) and Heat Shock Protein 90 (HSP90)
- (2018) Lianbin Yao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synergistic activity of BET inhibitor BI 894999 with PLK inhibitor volasertib in AML in vitro and in vivo
- (2018) Ulrike Tontsch-Grunt et al. CANCER LETTERS
- Nitric oxide-donating aspirin (NO-Aspirin) suppresses lung tumorigenesis in vitro and in vivo and these effects are associated with modulation of the EGFR signaling pathway
- (2018) Jung Min Song et al. CARCINOGENESIS
- Bis-coumarin Derivatives and Their Biological Activities
- (2018) Qing-Cheng Ren et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Design, synthesis and pharmacological evaluation of ALK and Hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs
- (2018) Kaijun Geng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7
- (2018) Eman F. Abdelhaleem et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors
- (2018) Hany A.M. El-Sherief et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and characterization of α -lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors
- (2018) Hong-Yan Lin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nitric oxide donors for prostate and bladder cancers: Current state and challenges
- (2018) Amedea B. Seabra et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Molecular Consortia—Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
- (2018) Mohamed Zayed et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization
- (2018) Saleh Ihmaid et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections
- (2018) Yahui Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Topoisomerase II Inhibitors by Medicinal Chemistry Approaches
- (2018) Wei Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously
- (2018) Jie Zang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N1-(4-((7-Cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)phenyl)-N8-hydroxyoctanediamide as a Novel Inhibitor Targeting Cyclin-dependent Kinase 4/9 (CDK4/9) and Histone Deacetlyase1 (HDAC1) against Malignant Cancer
- (2018) Yongtao Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer
- (2018) Fengyi Mao et al. MOLECULAR CANCER THERAPEUTICS
- Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives as Potent Antitumor Agents
- (2018) Yalan Guo et al. ACS Medicinal Chemistry Letters
- Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
- (2018) Ryo Tamura et al. Oncogenesis
- Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis
- (2018) John Mascarenhas et al. JAMA Oncology
- Design and synthesis of potent dual inhibitors of JAK2 and HDAC based on fusing the pharmacophores of XL019 and vorinostat
- (2018) Yu-yi Chu-Farseeva et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A comprehensive review of protein kinase inhibitors for cancer therapy
- (2018) Radhamani Kannaiyan et al. Expert Review of Anticancer Therapy
- Review of Drug Repositioning Approaches and Resources
- (2018) Hanqing Xue et al. International Journal of Biological Sciences
- Synthesis, Evaluation for Cytotoxicity and Molecular Docking Studies of Benzo[c]furan-Chalcones for Potential to Inhibit Tubulin Polymerization and/or EGFR-Tyrosine Kinase Phosphorylation
- (2018) Malose Mphahlele et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Design, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors
- (2018) Mohammed K. AbdElhameid et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Structure-Guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) Inhibitors
- (2018) Shuai Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of 3-aryl-quinolin derivatives as anti-breast cancer agents targeting ERα and VEGFR-2
- (2018) Xinyu Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective
- (2018) Aimie E. Garces et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy
- (2018) Tatsuya Nagano et al. Cells
- Discovery of novel antitumor nitric oxide-donating β -elemene hybrids through inhibiting the PI3K/Akt pathway
- (2017) Jichao Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer
- (2017) Guoshun Luo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent advances (2015–2016) in anticancer hybrids
- (2017) Nagaraju Kerru et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents
- (2017) Tooba Abdizadeh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The safety and efficacy of dabrafenib and trametinib for the treatment of melanoma
- (2017) Sarah Knispel et al. Expert Opinion On Drug Safety
- Enhanced aggressiveness of bystander cells in an anti-tumor photodynamic therapy model: Role of nitric oxide produced by targeted cells
- (2017) Jerzy Bazak et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mechanisms of Resistance to JAK2 Inhibitors in Myeloproliferative Neoplasms
- (2017) Sara C. Meyer HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Microtubule Depolymerization by Kinase Inhibitors: Unexpected Findings of Dual Inhibitors
- (2017) Kenji Tanabe INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology
- (2017) Florent Beaufils et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat
- (2017) Lianbin Yao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent Highlights on Molecular Hybrids Potentially Useful in Central Nervous System Disorders
- (2017) Mariana Matias et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics
- (2017) Stuart W. Ember et al. MOLECULAR CANCER THERAPEUTICS
- Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
- (2017) Mohamed Alswah et al. MOLECULES
- A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
- (2017) Stephen Leong et al. ONCOLOGIST
- Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08‐20
- (2017) Yehuda Patt et al. ONCOLOGIST
- Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer
- (2017) Yvette N. Lamb et al. Targeted Oncology
- Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives
- (2017) Dong Lu et al. ACS Medicinal Chemistry Letters
- Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
- (2017) Christian Grommes et al. Cancer Discovery
- Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways
- (2017) Pablo Garrido et al. Oncotarget
- Design, synthesis and biological evaluation of 2,3-dihydroimidazo[1,2-c]quinazoline derivatives as novel phosphatidylinositol 3-kinase and histone deacetylase dual inhibitors
- (2017) Yichao Wu et al. RSC Advances
- On the Integration of In Silico Drug Design Methods for Drug Repurposing
- (2017) Eric March-Vila et al. Frontiers in Pharmacology
- Conformational Adaption May Explain the Slow Dissociation Kinetics of Roniciclib (BAY 1000394), a Type I CDK Inhibitor with Kinetic Selectivity for CDK2 and CDK9
- (2016) Pelin Ayaz et al. ACS Chemical Biology
- The PI3K/AKT Pathway as a Target for Cancer Treatment
- (2016) Ingrid A. Mayer et al. Annual Review of Medicine
- A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells
- (2016) Chih-Wei Chen et al. APOPTOSIS
- Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success
- (2016) John A. Halsall et al. BIOESSAYS
- The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis
- (2016) Bethany T. Samuelson et al. BLOOD COAGULATION & FIBRINOLYSIS
- HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC- Driven Medulloblastoma
- (2016) Yanxin Pei et al. CANCER CELL
- Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib
- (2016) Jeffrey C. Bryan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- miR-181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF1 expression
- (2016) Junya Azumi et al. CANCER SCIENCE
- MiR-520b/e Regulates Proliferation and Migration by Simultaneously Targeting EGFR in Gastric Cancer
- (2016) Shuang Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer
- (2016) D. Kazandjian et al. CLINICAL CANCER RESEARCH
- Epidermal Growth Factor Receptor (EGFR) and its Cross-Talks with Topoisomerases: Challenges and Opportunities for Multi-Target Anticancer Drugs
- (2016) Monika Chauhan et al. CURRENT PHARMACEUTICAL DESIGN
- Design, synthesis and evaluation of 6-aryl-indenoisoquinolone derivatives dual targeting ERα and VEGFR-2 as anti-breast cancer agents
- (2016) Zhichao Tang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent advances of cytotoxic chalconoids targeting tubulin polymerization: Synthesis and biological activity
- (2016) Hassan Mirzaei et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Hybrid molecules: The privileged scaffolds for various pharmaceuticals
- (2016) Shaveta et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC
- (2016) Fan-Wei Peng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines
- (2016) Eugene Guorong Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy
- (2016) Ying-Qing Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
- (2016) Paolo A Ascierto et al. LANCET ONCOLOGY
- Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma
- (2016) Tram Anh Tran et al. MOLECULAR AND CELLULAR BIOLOGY
- Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells
- (2016) Yong-Chao Ma et al. PLoS One
- Selective use of sorafenib in the treatment of thyroid cancer
- (2016) Fabián Pitoia et al. Drug Design Development and Therapy
- In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC
- (2016) Susan Heavey et al. Oncotarget
- Dual inhibitors of epidermal growth factor receptor and topoisomerase IIα derived from a quinoline scaffold
- (2016) Monika Chauhan et al. RSC Advances
- Design, synthesis and biological evaluation of 2-amino-N-(2-aminophenyl)thiazole-5-carboxamide derivatives as novel Bcr-Abl and histone deacetylase dual inhibitors
- (2016) Xin Chen et al. RSC Advances
- Epigenetic polypharmacology: from combination therapy to multitargeted drugs
- (2016) Angel R. de Lera et al. Clinical Epigenetics
- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
- (2016) Linda S. Steelman et al. Aging-US
- Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase
- (2015) Fan-Wei Peng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy
- (2015) Elias E. Stratikopoulos et al. CANCER CELL
- Phase I/II study of gefitinib (Iressa®) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer
- (2015) Ji-Youn Han et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The role of heat shock proteins in cancer
- (2015) Georgios D. Lianos et al. CANCER LETTERS
- Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas
- (2015) Harvey Schwartz et al. CELL STRESS & CHAPERONES
- Discovery of Chemical Inhibitors of Human Bromodomains
- (2015) Guangtao Zhang et al. CHEMICAL REVIEWS
- Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma
- (2015) Q. Yang et al. CLINICAL CANCER RESEARCH
- FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
- (2015) J. A. Beaver et al. CLINICAL CANCER RESEARCH
- PI3K inhibitors in inflammation, autoimmunity and cancer
- (2015) Anne-Katrien Stark et al. CURRENT OPINION IN PHARMACOLOGY
- Tubulins - The Target for Anticancer Therapy
- (2015) N.G. Vindya et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation
- (2015) Mingfeng Yu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity
- (2015) Camillo Porta et al. Future Oncology
- Epigenetic-based therapy: From single- to multi-target approaches
- (2015) Rosaria Benedetti et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
- (2015) Wen Zhang et al. International Journal of Biological Sciences
- Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent
- (2015) Bing Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors
- (2015) F. Anthony Romero et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protein localization vector propagation: a method for improving the accuracy of drug repositioning
- (2015) Yunku Yeu et al. Molecular BioSystems
- Molecular Docking and Structure-Based Drug Design Strategies
- (2015) Leonardo Ferreira et al. MOLECULES
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- Control of microtubule organization and dynamics: two ends in the limelight
- (2015) Anna Akhmanova et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization
- (2015) S Mahale et al. Cell Death & Disease
- BRD4 Structure–Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536
- (2015) Lijia Chen et al. ACS Medicinal Chemistry Letters
- H89 enhances the sensitivity of cancer cells to glyceryl trinitrate through a purinergic receptor-dependent pathway
- (2015) Marion Cortier et al. Oncotarget
- S-nitrosylation in TNF superfamily signaling pathway: Implication in cancer
- (2015) Stéphanie Plenchette et al. Redox Biology
- mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells
- (2015) Brandon R. Beagle et al. Oncotarget
- Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
- (2014) Stuart W. J. Ember et al. ACS Chemical Biology
- Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors
- (2014) Elena Casale et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Recent developments in biological activities of chalcones: A mini review
- (2014) Parvesh Singh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The contribution of αβ-tubulin curvature to microtubule dynamics
- (2014) Gary J. Brouhard et al. JOURNAL OF CELL BIOLOGY
- De Novo Design of Multitarget Ligands with an Iterative Fragment-Growing Strategy
- (2014) Erchang Shang et al. Journal of Chemical Information and Modeling
- Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
- (2014) James D. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hybrids of Phenylsulfonylfuroxan and Coumarin as Potent Antitumor Agents
- (2014) Ming-Ming Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
- (2014) B T Gjertsen et al. LEUKEMIA
- Targeting Microtubules by Natural Agents for Cancer Therapy
- (2014) E. Mukhtar et al. MOLECULAR CANCER THERAPEUTICS
- Hybrid Curcumin Compounds: A New Strategy for Cancer Treatment
- (2014) Marie-Hélène Teiten et al. MOLECULES
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosis
- (2014) P. S. Winter et al. Science Signaling
- A versatile acid-labile linker for antibody–drug conjugates
- (2014) Mathew C. Finniss et al. MedChemComm
- Cyclin-dependent kinases
- (2014) Marcos Malumbres GENOME BIOLOGY
- Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers
- (2013) Kai Hung Tiong et al. APOPTOSIS
- Structure–activity relationships of bisphenol A analogs at estrogen receptors (ERs): Discovery of an ERα-selective antagonist
- (2013) Keisuke Maruyama et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PDK1 inhibition is a novel therapeutic target in multiple myeloma
- (2013) S Fujiwara et al. BRITISH JOURNAL OF CANCER
- The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways
- (2013) Juraj Bodo et al. BRITISH JOURNAL OF HAEMATOLOGY
- EGFR-TKI Resistance Due to BIM Polymorphism Can Be Circumvented in Combination with HDAC Inhibition
- (2013) T. Nakagawa et al. CANCER RESEARCH
- Targeting Src and Tubulin in Mucinous Ovarian Carcinoma
- (2013) T. Liu et al. CLINICAL CANCER RESEARCH
- Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer
- (2013) T. M. Zaid et al. CLINICAL CANCER RESEARCH
- What is next beyond janus kinase 2 inhibitors for primary myelofibrosis?
- (2013) Fabio P.S. Santos et al. CURRENT OPINION IN HEMATOLOGY
- Advances in the development of hybrid anticancer drugs
- (2013) Sébastien Fortin et al. Expert Opinion on Drug Discovery
- Sensitivity and resistance of JAK2 inhibitors to myeloproliferative neoplasms
- (2013) Neha Bhagwat et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- De Novo Design of Drug-Like Molecules by a Fragment-Based Molecular Evolutionary Approach
- (2013) Kentaro Kawai et al. Journal of Chemical Information and Modeling
- Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma
- (2013) Zu-Yau Lin et al. LIFE SCIENCES
- Synergistic Combination of Novel Tubulin Inhibitor ABI-274 and Vemurafenib Overcomes Vemurafenib Acquired Resistance in BRAFV600E Melanoma
- (2013) J. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Structural Determinants of Protein Kinase CK2 Regulation by Autoinhibitory Polymerization
- (2012) Graziano Lolli et al. ACS Chemical Biology
- The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II
- (2012) Brian B. Hasinoff et al. BIOCHEMICAL PHARMACOLOGY
- The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
- (2012) Piotr Rutkowski et al. BMC CANCER
- Vandetanib for the Treatment of Medullary Thyroid Cancer
- (2012) N. G. Chau et al. CLINICAL CANCER RESEARCH
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
- (2012) L. Neckers et al. CLINICAL CANCER RESEARCH
- Pazopanib for the Treatment of Metastatic Renal Cell Carcinoma
- (2012) Amy M. Pick et al. CLINICAL THERAPEUTICS
- Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease
- (2012) Apostolos Kontzias et al. CURRENT OPINION IN PHARMACOLOGY
- The Therapeutic Target Hsp90 and Cancer Hallmarks
- (2012) Yoshihiko Miyata et al. CURRENT PHARMACEUTICAL DESIGN
- The bromodomain interaction module
- (2012) Panagis Filippakopoulos et al. FEBS LETTERS
- Microtubule inhibition causes epidermal growth factor receptor inactivation in oesophageal cancer cells
- (2012) XUPING WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target
- (2012) HOON HUR et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
- (2012) Sylvie Euvrard et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK/STAT signaling in hematological malignancies
- (2012) W Vainchenker et al. ONCOGENE
- Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr–Abl mutations and mutational analysis
- (2012) Simona Soverini et al. PHARMACOGENOMICS
- Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer
- (2011) Roberto Battistutta et al. BIOCHEMISTRY
- Hybrid Compounds
- (2011) Andreas Müller-Schiffmann et al. BIODRUGS
- PARP Inhibitor Treatment in Ovarian and Breast Cancer
- (2011) Marcie K. Weil et al. CURRENT PROBLEMS IN CANCER
- Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer
- (2011) K Ted Thurn et al. Future Oncology
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis and Evaluation of Hydrophilic Linkers for Antibody–Maytansinoid Conjugates
- (2011) Robert Y. Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- What Do Medicinal Chemists Actually Make? A 50-Year Retrospective
- (2011) W. Patrick Walters et al. JOURNAL OF MEDICINAL CHEMISTRY
- Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
- (2010) Elias Jabbour et al. CANCER
- Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain
- (2010) Rafael Rosell et al. Clinical & Translational Oncology
- Pharmacophore Based Drug Design Approach as a Practical Process in Drug Discovery
- (2010) Qingzhi Gao et al. Current Computer-Aided Drug Design
- Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: A potential clinical application of angiogenesis inhibitors
- (2010) Roshani R. Patel et al. EUROPEAN JOURNAL OF CANCER
- Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma
- (2010) Ghassan K. Abou-Alfa et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
- (2010) Fabrice Pierre et al. JOURNAL OF MEDICINAL CHEMISTRY
- Peptide-mediated targeted drug delivery
- (2010) Sumit Majumdar et al. MEDICINAL RESEARCH REVIEWS
- BMS-777607, a Small-Molecule Met Kinase Inhibitor, Suppresses Hepatocyte Growth Factor-Stimulated Prostate Cancer Metastatic Phenotype In vitro
- (2010) Y. Dai et al. MOLECULAR CANCER THERAPEUTICS
- Combination of Vorinostat and Flavopiridol Is Selectively Cytotoxic to Multidrug-Resistant Neuroblastoma Cell Lines with Mutant TP53
- (2010) J.-M. Huang et al. MOLECULAR CANCER THERAPEUTICS
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- Breast Cancer, Estrogen Receptor and Ligands
- (2009) Zhenlin Bai et al. ARCHIV DER PHARMAZIE
- PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol
- (2009) Arpad Szanto et al. BIOCHEMICAL PHARMACOLOGY
- Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
- (2009) F. Qian et al. CANCER RESEARCH
- Protein Kinase CK2 in Health and Disease
- (2009) N. A. St-Denis et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients
- (2009) L. M. McGlynn et al. CLINICAL CANCER RESEARCH
- The Role of Fibroblast Growth Factors in Tumor Growth
- (2009) M. Korc et al. CURRENT CANCER DRUG TARGETS
- Drug hybridization strategies: before or after lead identification?
- (2009) Carlos Alberto Manssour Fraga Expert Opinion on Drug Discovery
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases†
- (2009) Siavosh Mahboobi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Interaction of E1 and E3 components with the core proteins of the human pyruvate dehydrogenase complex
- (2009) Mulchand S. Patel et al. JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
- Cell cycle kinases as therapeutic targets for cancer
- (2009) Silvia Lapenna et al. NATURE REVIEWS DRUG DISCOVERY
- Kinase mutations in human disease: interpreting genotype–phenotype relationships
- (2009) Piya Lahiry et al. NATURE REVIEWS GENETICS
- Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations
- (2008) Egle Avizienyte et al. BIOCHEMICAL JOURNAL
- PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer
- (2008) S M Wigfield et al. BRITISH JOURNAL OF CANCER
- Aurora Kinases as Anticancer Drug Targets
- (2008) O. Gautschi et al. CLINICAL CANCER RESEARCH
- Use of sirolimus (rapamycin) to treat refractory Crohn's disease
- (2008) D C O Massey et al. GUT
- Identification of Nitric Oxide as an Endogenous Activator of the AMP-activated Protein Kinase in Vascular Endothelial Cells
- (2008) Junhua Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone Deacetylase Inhibitors: From Bench to Clinic
- (2008) Marielle Paris et al. JOURNAL OF MEDICINAL CHEMISTRY
- 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1
- (2008) Keith A. Menear et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase II Study of ABT-751 in Patients with Advanced Non-small Cell Lung Cancer
- (2008) Ann M. Mauer et al. Journal of Thoracic Oncology
- Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo
- (2008) D. Maksimovic-Ivanic et al. MOLECULAR CANCER THERAPEUTICS
- Novel therapeutic applications of nitric oxide donors in cancer: Roles in chemo- and immunosensitization to apoptosis and inhibition of metastases
- (2008) Benjamin Bonavida et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Hybrid Molecules with a Dual Mode of Action: Dream or Reality?†
- (2007) Bernard Meunier ACCOUNTS OF CHEMICAL RESEARCH
- Inhibition of tumor–stromal interaction through HGF/Met signaling by valproic acid
- (2007) Yohsuke Matsumoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now